MDR1 deficiency impairs mitochondrial homeostasis and promotes intestinal inflammation

G-T Ho1,2, R E Aird1,3, B Liu4

  • 1MRC Centre for Inflammation Research, Queens Medical Research Institute, University of Edinburgh, Edinburgh, UK.

Mucosal Immunology
|April 13, 2017
PubMed

Insights

The multidrug resistance-1 (MDR1) gene protects mitochondria from damage, preventing colitis. MDR1 deficiency increases mitochondrial reactive oxygen species (mROS), driving inflammatory bowel disease (IBD) development.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Genetics

Background:

  • The multidrug resistance-1 (MDR1) gene encodes an efflux transporter highly expressed in the colon.
  • MDR1 deficiency in mice causes colitis, mimicking human inflammatory bowel diseases (IBD).

Purpose of the Study:

  • To investigate the role of MDR1 in mitochondrial function and its connection to colitis development.
  • To explore the link between MDR1, mitochondrial reactive oxygen species (mROS), and IBD pathogenesis.

Main Methods:

  • Mice models with altered MDR1 and SOD2 gene expression were utilized.
  • Mitochondrial function, mROS levels, and colitis development were assessed.
  • Genome-wide association data for IBD susceptibility genes were analyzed.

Main Results:

  • MDR1 deficiency leads to mitochondrial dysfunction and increased mROS, exacerbating colitis.
  • Inhibition of mROS attenuated colitis, while induction accelerated it, especially in MDR1-deficient mice.
  • Human IBD patients showed a negative correlation between MDR1 and SOD2 expression; SOD2 deletion increased colitis susceptibility in mice.
  • A significant portion of IBD susceptibility genes are involved in mitochondrial homeostasis.

Conclusions:

  • MDR1 plays a protective role in mitochondria, preventing colitis by limiting mROS.
  • Mitochondrial dysfunction, driven by a combination of toxins and genetic susceptibility, represents a novel pathogenic mechanism in IBD.
  • These findings suggest new therapeutic strategies targeting mitochondrial pathways for IBD treatment.

Related Concept Videos

Mismatch Repair01:36

Mismatch Repair

Overview
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...